<DOC>
	<DOCNO>NCT02263209</DOCNO>
	<brief_summary>Prospective clinical investigation determine safety Taperloc stem BioGuard coat Exceed ABT Taperfit acetabular cup BioGuard coat use cementless total hip arthroplasty</brief_summary>
	<brief_title>Investigation Determine Safety Taperloc Stems With BioGuard Coating When Used Cementless Total Hip Arthroplasty</brief_title>
	<detailed_description>Bioguard Safety Study : Prospective clinical investigation determine safety Taperloc stem BioGuard coat Exceed ABT Taperfit acetabular cup BioGuard coat use cementless total hip arthroplasty</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<criteria>Eligible cementless primary total hip arthroplasty accord Surgical Technique brochure ( Appendix 10 ) : `` The Taperloc Porous Primary Hip Exceed ABT Taperfit Prostheses market noncemented use skeletally mature patient undergo primary hip replacement surgery non inflammatory degenerative joint disease . '' Under 80 40 year age A preoperative level pain function conventional joint replacement . A likelihood obtain relief pain improved function Full skeletal maturity Ability follow instruction Good general health age Willing return followup evaluation Patients age 80 40 year Known allergy antibiotic Active infection Revision arthroplasty Marked bone loss could preclude compromise adequate fixation device Uncooperative subject Parkinson 's Disease Vascular insufficiency affect limb , could compromise bony ingrowth/implant fixation , i.e. , diabetes . Severe instability deformity ligament and/or surround soft tissue may preclude stability device Pregnancy BMI &gt; 40 Use immunosuppressive drug Women child bear potential</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>